Tag: CDMO

Almac Group strengthens its position in the CDMO market

almac
Almac Group, the global contract development and manufacturing organisation, announced its global analytical services capabilities spanning UK, Europe and USA.

Idifarma announced renewal of its EU-GMP certificate

api
Idifarma, a Spanish contract development and manufacturing organisation (CDMO), announced the installation of GEA Niro Mobile Minor equipment in a new dedicated area in its EU GMP plant.

Recipharm receives EMVO approval

recipharm
Recipharm, a leading contract development and manufacturing organisation has received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub.

Avara obtains sterile manufacturing facility from Sandoz

pharma-market
Avara Pharmaceutical Services announced that it has closed on the transaction with Sandoz to acquire the largest sterile manufacturing facility for injectable medicines in Canada.

AMRI signed collaboration agreement with Metrion Biosciences

lab
AMRI and Metrion Biosciences Limited, the specialist ion channel CRO and drug discovery company, announced they have signed a new collaboration agreement.

AGC will boost its GMP-compliant pharma production

chemistry
AGC announced a major expansion of facilities at its Chiba Plant that will result in an increase in the company’s GMP-compliant synthetic pharmaceutical intermediate and active ingredient production capacity.

Novacap acquires PCI Synthesis CDMO

research
Novacap announced that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO).

Stelis Biopharma and Oncobiologics start a new CDMO

biotechnologies
Marketed under the name, Bio2Source, Oncobiologics and Stelis Biopharma will offer development stage biotech companies access to a suite of CDMO services.

Global CDMO Recipharm makes its preparations for Brexit

investment
Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation.

Avara buys the largest sterile manufacturing facility in Canada

sterile-manufacturing
Avara Pharmaceutical Services, a world-class contract development and manufacturing organization acquires the largest sterile manufacturing facility for injectable medicines in Canada from a leading global pharmaceutical company.

Recipharm and Hadasit started a partnership

laboratory
Recipharm, the contract development and manufacturing organisation (CDMO), has partnered with Hadasit Medical Research Services and Development to offer combined clinical, biological and chemical services.

Ardena boosts its API manufacturing capabilities by acquiring Syntagon

api
Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.

Avid Bioservices will expand and optimize its capabilities

lab
Avid Bioservices, a dedicated contract development and manufacturing organization, published an update on the company's ongoing efforts to expand and optimize its process development capabilities and laboratory space.

Sterling Pharma will boost its API manufacturing capabilities

api
Contract development and manufacturing organisation Sterling Pharma Solutions is investing £6 million (approximately €6,86 million) into its pilot plant facility at its UK site.

Chinese CDMO receives funding to expand GMP manufacturing capabilities

manufacturing
CMAB Biopharma, a Chinese full-service contract development and manufacturing organization (CDMO) providing process development and manufacturing services for biologic products, raised $34 million fin...

Hanmi Pharmaceutical grows as the CDMO market player

hanmi pharmaceutical
South Korean Hanmi Pharmaceutical is progressing quickly on the CDMO market due to its innovations and investments. The Hanmi's Smart Plant was built last year on a 36,492 square meter site.